{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T19:33:56Z","timestamp":1784403236043,"version":"3.55.0"},"reference-count":81,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["KK.01.1.1.02.0007"],"award-info":[{"award-number":["KK.01.1.1.02.0007"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007259","name":"Institut Ru\u0111er Bo\u0161kovi\u0107","doi-asserted-by":"publisher","award":["KK.01.1.1.02.0007"],"award-info":[{"award-number":["KK.01.1.1.02.0007"]}],"id":[{"id":"10.13039\/501100007259","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004488","name":"Hrvatska Zaklada za Znanost","doi-asserted-by":"publisher","award":["UIP-2017-05-5160"],"award-info":[{"award-number":["UIP-2017-05-5160"]}],"id":[{"id":"10.13039\/501100004488","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004488","name":"Hrvatska Zaklada za Znanost","doi-asserted-by":"publisher","award":["KK.01.1.1.02.0021"],"award-info":[{"award-number":["KK.01.1.1.02.0021"]}],"id":[{"id":"10.13039\/501100004488","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.bmc.2024.117734","type":"journal-article","created":{"date-parts":[[2024,4,22]],"date-time":"2024-04-22T21:36:33Z","timestamp":1713821793000},"page":"117734","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Discovery of harmiprims, harmine-primaquine hybrids, as potent and selective anticancer and antimalarial compounds"],"prefix":"10.1016","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8523-6340","authenticated-orcid":false,"given":"Kristina","family":"Pavi\u0107","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Goran","family":"Poje","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lais","family":"Pessanha de Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1430-5107","authenticated-orcid":false,"given":"Tana","family":"Tandari\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Marinovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0046-648X","authenticated-orcid":false,"given":"Diana","family":"Fontinha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7970-1429","authenticated-orcid":false,"given":"Jana","family":"Held","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1746-6029","authenticated-orcid":false,"given":"Miguel","family":"Prud\u00eancio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivo","family":"Piantanida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Vianello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivona","family":"Kro\u0161l Kne\u017eevi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8644-0223","authenticated-orcid":false,"given":"Ivana","family":"Perkovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zrinka","family":"Raji\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2024.117734_b0005","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s13027-021-00370-7","article-title":"Malaria and cancer: a critical review on the established associations and new perspectives","volume":"16","author":"Ellis","year":"2021","journal-title":"Infect Agent Cancer"},{"key":"10.1016\/j.bmc.2024.117734_b0010","unstructured":"Https:\/\/Www.Who.Int\/News-Room\/Fact-Sheets\/Detail\/the-Top-10-Causes-of-Death [Accessed 20th January 2024]."},{"key":"10.1016\/j.bmc.2024.117734_b0015","unstructured":"World Malaria Report 2023. World Health Organisation 2023. https:\/\/www.who.int\/publications\/i\/item\/9789240086173 [Accessed 9th March 2024]."},{"key":"10.1016\/j.bmc.2024.117734_b0020","unstructured":"Https:\/\/Www.Who.Int\/Health-Topics\/Cancer#tab=tab_1 [Accessed 21 January 2024]."},{"key":"10.1016\/j.bmc.2024.117734_b0025","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/s41586-019-1730-1","article-title":"A View on Drug Resistance in Cancer","volume":"575","author":"Vasan","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.bmc.2024.117734_b0030","doi-asserted-by":"crossref","first-page":"77","DOI":"10.4103\/2279-042X.179560","article-title":"Drug Interactions in cancer patients: a hidden risk?","volume":"5","author":"Riechelmann","year":"2016","journal-title":"J Res Pharm Pract."},{"key":"10.1016\/j.bmc.2024.117734_b0035","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s12936-022-04047-3","article-title":"Strengthening therapeutic adherence and pharmacovigilance to antimalarial treatment in Manaus, Brazil: a multicomponent strategy using mHealth","volume":"21","author":"Mac\u00edas Saint-Gerons","year":"2022","journal-title":"Malar J"},{"key":"10.1016\/j.bmc.2024.117734_b0040","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s12936-023-04507-4","article-title":"Adherence to severe malaria treatment guidelines in children at a Ugandan regional hospital: a baseline assessment for a malaria treatment quality improvement project","volume":"22","author":"Moffitt","year":"2023","journal-title":"Malar J"},{"key":"10.1016\/j.bmc.2024.117734_b0045","series-title":"In Advances in Cancer Research. Elsevier","first-page":"1","article-title":"An overview of chemotoxicity and radiation toxicity in cancer therapy","author":"Yazbeck","year":"2022"},{"key":"10.1016\/j.bmc.2024.117734_b0050","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1038\/bjc.2013.48","article-title":"Prevalence of potential drug-drug interactions in cancer patients treated with oral anticancer drugs","volume":"108","author":"Van Leeuwen","year":"2013","journal-title":"Br J Cancer"},{"key":"10.1016\/j.bmc.2024.117734_b0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111640","article-title":"Primaquine derivatives: modifications of the terminal amino group","volume":"182","author":"Zorc","year":"2019","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2024.117734_b0060","first-page":"2807","article-title":"Chloroquine inhibits cell growth in human A549 lung cancer cells by blocking autophagy and inducing mitochondrial-mediated apoptosis","volume":"39","author":"Liu","year":"2018","journal-title":"Oncol Rep"},{"key":"10.1016\/j.bmc.2024.117734_b0065","doi-asserted-by":"crossref","first-page":"2300086","DOI":"10.1002\/adbi.202300086","article-title":"Therapeutical utilization and repurposing of artemisinin and its derivatives: a narrative review","volume":"7","author":"Guan","year":"2023","journal-title":"Adv Biol."},{"key":"10.1016\/j.bmc.2024.117734_b0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.115000","article-title":"A comprehensive overview of artemisinin and its derivatives as anticancer agents","volume":"247","author":"Zeng","year":"2023","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2024.117734_b0075","doi-asserted-by":"crossref","first-page":"204","DOI":"10.2174\/1574892815666210106111012","article-title":"Repurposing chloroquine analogs as an adjuvant cancer therapy","volume":"16","author":"Fong","year":"2021","journal-title":"Recent Patents Anticancer Drug Discov."},{"key":"10.1016\/j.bmc.2024.117734_b0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111275","article-title":"Repurposing of existing therapeutics to combat drug-resistant malaria","volume":"136","author":"Yadav","year":"2021","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.bmc.2024.117734_b0085","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1093\/infdis\/jiq024","article-title":"Methotrexate is highly potent against pyrimethamine-resistant plasmodium vivax","volume":"203","author":"Imwong","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.bmc.2024.117734_b0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113688","article-title":"A comprehensive overview of \u03b2-carbolines and its derivatives as anticancer agents","volume":"224","author":"Luo","year":"2021","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2024.117734_b0095","doi-asserted-by":"crossref","first-page":"2300091","DOI":"10.1002\/ardp.202300091","article-title":"Review of \u03b2-carboline and its derivatives as selective MAO-A inhibitors","volume":"356","author":"Benny","year":"2023","journal-title":"Arch Pharm (weinheim)."},{"key":"10.1016\/j.bmc.2024.117734_b0100","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1007\/s12272-020-01283-6","article-title":"Pharmacological effects of Harmine and its derivatives: a review","volume":"43","author":"Zhang","year":"2020","journal-title":"Arch Pharm Res"},{"key":"10.1016\/j.bmc.2024.117734_b0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113536","article-title":"Structure activity relationship in \u03b2-carboline derived anti-malarial agents","volume":"221","author":"Kamboj","year":"2021","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2024.117734_b0110","doi-asserted-by":"crossref","first-page":"4207","DOI":"10.1128\/AAC.00328-12","article-title":"Harmine is a potent antimalarial targeting Hsp90 and synergises with chloroquine and artemisinin","volume":"56","author":"Shahinas","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bmc.2024.117734_b0115","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1186\/s12936-016-1625-7","article-title":"In vitro and in vivo anti-malarial activity of novel harmine-analog heat shock protein 90 inhibitors: a possible partner for artemisinin","volume":"15","author":"Bayih","year":"2016","journal-title":"Malar J"},{"key":"10.1016\/j.bmc.2024.117734_b0120","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.3892\/or.2017.5952","article-title":"Harmine suppresses the proliferation and migration of human ovarian cancer cells through inhibiting ERK\/CREB pathway","volume":"38","author":"Gao","year":"2017","journal-title":"Oncol Rep"},{"key":"10.1016\/j.bmc.2024.117734_b0125","first-page":"2612","article-title":"Harmine suppresses breast cancer cell migration and invasion by regulating TAZ-mediated epithelial-mesenchymal transition","volume":"12","author":"He","year":"2022","journal-title":"Am J Cancer Res"},{"key":"10.1016\/j.bmc.2024.117734_b0130","doi-asserted-by":"crossref","first-page":"3363","DOI":"10.3892\/or.2016.4695","article-title":"Harmine induces cell cycle arrest and mitochondrial pathway-mediated cellular apoptosis in SW620 cells via inhibition of the akt and ERK signaling pathways","volume":"35","author":"Liu","year":"2016","journal-title":"Oncol Rep"},{"key":"10.1016\/j.bmc.2024.117734_b0135","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.phymed.2017.02.008","article-title":"Anticancer activities of harmine by inducing a pro-death autophagy and apoptosis in human gastric cancer cells","volume":"28","author":"Li","year":"2017","journal-title":"Phytomedicine"},{"key":"10.1016\/j.bmc.2024.117734_b0140","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20190155","article-title":"Harmine suppresses bladder tumor growth by suppressing vascular endothelial growth factor receptor 2-mediated angiogenesis","volume":"39","author":"Hai-rong","year":"2019","journal-title":"Biosci Rep"},{"key":"10.1016\/j.bmc.2024.117734_b0145","doi-asserted-by":"crossref","first-page":"5880","DOI":"10.1080\/07391102.2021.1874533","article-title":"Structure-activity insights of harmine targeting DNA, ROS inducing cytotoxicity with PARP mediated apoptosis against cervical cancer, anti-biofilm formation and in vivo therapeutic study","volume":"40","author":"Sarkar","year":"2022","journal-title":"J Biomol Struct Dyn"},{"key":"10.1016\/j.bmc.2024.117734_b0150","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ejmech.2017.05.059","article-title":"Recent insights into synthetic \u03b2 -carbolines with anti-cancer activities","volume":"142","author":"Kumar","year":"2017","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2024.117734_b0155","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.ejmech.2018.08.027","article-title":"\u03b2-Carboline alkaloid monomers and dimers: occurrence, structural diversity, and biological activities","volume":"157","author":"Dai","year":"2018","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2024.117734_b0160","doi-asserted-by":"crossref","unstructured":"Aaghaz S, Sharma K, Jain R, Kamal A. \u03b2-Carbolines as potential anticancer agents. Eur J Med Chem. 216;2021:113321. DOI: 10.1016\/j.ejmech.2021.113321.","DOI":"10.1016\/j.ejmech.2021.113321"},{"key":"10.1016\/j.bmc.2024.117734_b0165","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1039\/D0MD00422G","article-title":"\u03b2-Carboline-based molecular hybrids as anticancer agents: a brief sketch","volume":"12","author":"Soni","year":"2021","journal-title":"RSC Med Chem."},{"key":"10.1016\/j.bmc.2024.117734_b0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115247","article-title":"Current development of \u03b2-carboline derived potential antimalarial scaffolds","volume":"252","author":"Kushwaha","year":"2023","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2024.117734_b0175","doi-asserted-by":"crossref","first-page":"111927","DOI":"10.1016\/j.ejmech.2019.111927","article-title":"Harmicines \u2013 harmine and cinnamic acid hybrids as novel antiplasmodial hits","volume":"187","author":"Perkovi\u0107","year":"2020","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2024.117734_b0180","doi-asserted-by":"crossref","first-page":"4376","DOI":"10.3390\/molecules25194376","article-title":"Novel harmicines with improved potency against Plasmodium","volume":"25","author":"Marinovi\u0107","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.bmc.2024.117734_b0185","doi-asserted-by":"crossref","first-page":"113687","DOI":"10.1016\/j.ejmech.2021.113687","article-title":"Further investigation of harmicines as novel antiplasmodial agents: Synthesis, structure-activity relationship and insight into the mechanism of action","volume":"224","author":"Marinovi\u0107","year":"2021","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2024.117734_b0190","doi-asserted-by":"crossref","first-page":"114408","DOI":"10.1016\/j.ejmech.2022.114408","article-title":"Design and synthesis of harmiquins, harmine and chloroquine hybrids as potent antiplasmodial agents","volume":"238","author":"Poje","year":"2022","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2024.117734_b0195","doi-asserted-by":"crossref","first-page":"6490","DOI":"10.3390\/molecules26216490","article-title":"Synthesis and biological evaluation of Harmirins, novel Harmine-Coumarin hybrids as potential anticancer agents","volume":"26","author":"Pavi\u0107","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.bmc.2024.117734_b0200","doi-asserted-by":"crossref","first-page":"9315","DOI":"10.3390\/ijms23169315","article-title":"Novel harmine and ferrocene hybrids: design, synthesis and biological activity","volume":"23","author":"Poje","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.bmc.2024.117734_b0205","doi-asserted-by":"crossref","first-page":"117468","DOI":"10.1016\/j.bmc.2023.117468","article-title":"Design, synthesis and antiplasmodial evaluation of new amide-, carbamate-, and ureido-type harmicines","volume":"94","author":"Marinovi\u0107","year":"2023","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmc.2024.117734_b0210","doi-asserted-by":"crossref","first-page":"537","DOI":"10.2478\/acph-2023-0035","article-title":"Synthesis, antiproliferative and antiplasmodial evaluation of new chloroquine and mefloquine-based harmiquins","volume":"73","author":"Pavi\u0107","year":"2023","journal-title":"Acta Pharm"},{"key":"10.1016\/j.bmc.2024.117734_b0215","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.ejmech.2008.08.011","article-title":"Primaquine revisited six decades after its discovery","volume":"44","author":"Vale","year":"2009","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2024.117734_b0220","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1021\/acs.jmedchem.9b01541","article-title":"Urea derivatives in modern drug discovery and medicinal chemistry","volume":"63","author":"Ghosh","year":"2020","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2024.117734_b0225","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1016\/j.drudis.2017.05.014","article-title":"The 1,2,3-Triazole ring as a bioisostere in medicinal chemistry","volume":"22","author":"Bonandi","year":"2017","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.bmc.2024.117734_b0230","doi-asserted-by":"crossref","first-page":"3797","DOI":"10.1021\/ol701581g","article-title":"An efficient, inexpensive, and shelf-stable diazotransfer reagent: imidazole-1-sulfonyl azide hydrochloride","volume":"9","author":"Goddard-Borger","year":"2007","journal-title":"Org Lett"},{"key":"10.1016\/j.bmc.2024.117734_b0235","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1016\/j.ejmech.2007.09.001","article-title":"The novel primaquine derivatives of N-alkyl, cycloalkyl or aryl urea: synthesis, cytostatic and antiviral activity evaluations","volume":"43","author":"D\u017eimbeg","year":"2008","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2024.117734_b0240","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1128\/aem.47.3.540-543.1984","article-title":"Production of a novel dimeric metabolite of primaquine by Streptomyces Rimosus","volume":"47","author":"Clark","year":"1984","journal-title":"Appl Environ Microbiol"},{"key":"10.1016\/j.bmc.2024.117734_b0245","doi-asserted-by":"crossref","first-page":"3587","DOI":"10.1016\/S0960-894X(02)00802-8","article-title":"Isolation and antimalarial activity of peroxydisulfate oxidation products of primaquine","volume":"12","author":"Dua","year":"2002","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmc.2024.117734_b0250","doi-asserted-by":"crossref","first-page":"3859","DOI":"10.1002\/chem.201102968","article-title":"Kinetic differentiation between homo- and alternating AT DNA by sterically restricted phosphonium dyes","volume":"18","author":"Tumir","year":"2012","journal-title":"Chem \u2013 Eur J"},{"key":"10.1016\/j.bmc.2024.117734_b0255","series-title":"Small molecule DNA and RNA binders","author":"Demeunynck","year":"2004"},{"key":"10.1016\/j.bmc.2024.117734_b0260","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/0022-2836(74)90031-X","article-title":"Theoretical aspects of DNA-protein interactions: Co-operative and non-co-operative binding of large ligands to a one-dimensional homogeneous lattice","volume":"86","author":"McGhee","year":"1974","journal-title":"J Mol Biol"},{"key":"10.1016\/j.bmc.2024.117734_b0265","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1111\/j.1749-6632.1949.tb27297.x","article-title":"The attractions of proteins for small molecules and ions","volume":"51","author":"Scatchard","year":"1949","journal-title":"Ann. New York Acad. Sci"},{"key":"10.1016\/j.bmc.2024.117734_b0270","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1089\/154545703322860825","article-title":"Analysis of thermal melting curves","volume":"13","author":"Mergny","year":"2003","journal-title":"Oligonucleotides"},{"key":"10.1016\/j.bmc.2024.117734_b0275","series-title":"Circular dichroism and linear dichroism","author":"Norden","year":"1997"},{"key":"10.1016\/j.bmc.2024.117734_b0280","doi-asserted-by":"crossref","first-page":"84","DOI":"10.3762\/bjoc.14.5","article-title":"Polarization spectroscopy methods in the determination of interactions of small molecules with nucleic acids \u2013 tutorial","volume":"14","author":"\u0160midlehner","year":"2018","journal-title":"Beilstein J Org Chem"},{"key":"10.1016\/j.bmc.2024.117734_b0285","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.3390\/molecules24152812","article-title":"Primaquine and chloroquine fumardiamides as promising antiplasmodial agents","volume":"24","author":"Beus","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.bmc.2024.117734_b0290","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/1475-2875-12-212","article-title":"The metabolism of primaquine to its active metabolite is dependent on CYP 2D6","volume":"12","author":"Pybus","year":"2013","journal-title":"Malar J"},{"key":"10.1016\/j.bmc.2024.117734_b0295","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1021\/jm980403y","article-title":"Structural basis for inhibition of the Hsp90 molecular chaperone by the antitumor antibiotics radicicol and geldanamycin","volume":"42","author":"Roe","year":"1999","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2024.117734_b0300","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1002\/prot.22799","article-title":"Structure of the ATP-binding domain of plasmodium falciparum Hsp90","volume":"78","author":"Corbett","year":"2010","journal-title":"Proteins Struct Funct Bioinforma."},{"key":"10.1016\/j.bmc.2024.117734_b0305","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S1056-8719(02)00166-1","article-title":"The power issue: determination of KB or Ki from IC50","volume":"46","author":"Cheng","year":"2001","journal-title":"J Pharmacol Toxicol Methods"},{"key":"10.1016\/j.bmc.2024.117734_b0310","doi-asserted-by":"crossref","first-page":"3828","DOI":"10.1096\/fj.11-188821","article-title":"Features of the streptomyces hygroscopicus HtpG reveal how partial geldanamycin resistance can arise with mutation to the ATP binding pocket of a eukaryotic Hsp90","volume":"25","author":"Millson","year":"2011","journal-title":"FASEB J"},{"key":"10.1016\/j.bmc.2024.117734_b0315","first-page":"837","article-title":"Reactions with 1-Benzotriazole Carboxylic Acid Chloride. I. Synthesis of the 2,6-Bis(Hydroxymethyl)Pyridine Dicarbamates","volume":"49","author":"Vela","year":"1977","journal-title":"Croat Chem Acta"},{"key":"10.1016\/j.bmc.2024.117734_b0320","doi-asserted-by":"crossref","first-page":"3933","DOI":"10.1021\/bi00260a005","article-title":"Studies on interaction of anthracycline antibiotics and deoxyribonucleic acid: equilibrium binding studies on the interaction of daunomycin with deoxyribonucleic acid","volume":"21","author":"Chaires","year":"1982","journal-title":"Biochemistry"},{"key":"10.1016\/j.bmc.2024.117734_b0325","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1039\/a905307g","article-title":"The interaction of New 4,9-diazapyrenium compounds with double stranded nucleic acids","volume":"2","author":"Palm","year":"2000","journal-title":"J Chem Soc, Perkin Trans"},{"key":"10.1016\/j.bmc.2024.117734_b0330","doi-asserted-by":"crossref","first-page":"6378","DOI":"10.1128\/AAC.03326-14","article-title":"Antimalarial activity of the myxobacterial macrolide chlorotonil A","volume":"58","author":"Held","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bmc.2024.117734_b0335","doi-asserted-by":"crossref","first-page":"3575","DOI":"10.1128\/AAC.49.8.3575-3577.2005","article-title":"Simple histidine-rich protein 2 double-site sandwich enzyme-linked immunosorbent assay for use in malaria drug sensitivity testing","volume":"49","author":"Noedl","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bmc.2024.117734_b0340","unstructured":"R Core Team. A language and environment for statistical computing. R foundation for statistical computing. Vienna, Austria. https:\/\/www.R-project.org\/. [Accessed 20 December 2021]."},{"key":"10.1016\/j.bmc.2024.117734_b0345","doi-asserted-by":"crossref","first-page":"329","DOI":"10.3389\/fcimb.2017.00329","article-title":"Inhibition of Plasmodium hepatic infection by antiretroviral compounds","volume":"7","author":"Machado","year":"2017","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.bmc.2024.117734_b0350","doi-asserted-by":"crossref","first-page":"e7881","DOI":"10.1371\/journal.pone.0007881","article-title":"Visualisation and quantitative analysis of the rodent malaria liver stage by real time imaging","volume":"4","author":"Ploemen","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.bmc.2024.117734_b0355","doi-asserted-by":"crossref","first-page":"e35019","DOI":"10.1371\/journal.pone.0035019","article-title":"Activity of Clinically relevant antimalarial drugs on plasmodium falciparum mature gametocytes in an ATP bioluminescence \u201ctransmission blocking\u201d assay","volume":"7","author":"Leli\u00e8vre","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.bmc.2024.117734_b0360","first-page":"e00085","article-title":"Ivermectin impairs the development of sexual and asexual stages of plasmodium falciparum in vitro","volume":"63","author":"Pessanha De Carvalho","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bmc.2024.117734_b0365","doi-asserted-by":"crossref","first-page":"6177","DOI":"10.1021\/jm051256o","article-title":"Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein\u2212ligand complexes","volume":"49","author":"Friesner","year":"2006","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2024.117734_b0370","unstructured":"Schr\u00f6dinger Release 2023-4: LigPrep. Schr\u00f6dinger, LLC. New York, NY, 2023."},{"key":"10.1016\/j.bmc.2024.117734_b0375","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1021\/jm030644s","article-title":"A new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening","volume":"47","author":"Halgren","year":"2004","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2024.117734_b0380","unstructured":"Frisch MJ, Trucks GW, Schlegel HB, et al. Gaussian 16, 2016."},{"key":"10.1016\/j.bmc.2024.117734_b0385","unstructured":"Case DA, Betz RM, Cerutti DS, et al. Amber 16, 2016."},{"key":"10.1016\/j.bmc.2024.117734_b0390","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1517\/17460441.2015.1032936","article-title":"The MM\/PBSA and MM\/GBSA methods to estimate ligand-binding affinities","volume":"10","author":"Genheden","year":"2015","journal-title":"Expert Opin Drug Discov"},{"key":"10.1016\/j.bmc.2024.117734_b0395","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1021\/ci100275a","article-title":"Assessing the performance of the MM\/PBSA and MM\/GBSA methods. 1. The accuracy of binding free energy calculations based on molecular dynamics simulations","volume":"51","author":"Hou","year":"2011","journal-title":"J Chem Inf Model"},{"key":"10.1016\/j.bmc.2024.117734_b0400","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1002\/jcc.21372","article-title":"Fast and accurate predictions of binding free energies using MM-PBSA and MM-GBSA","volume":"31","author":"Rastelli","year":"2010","journal-title":"J Comput Chem"},{"key":"10.1016\/j.bmc.2024.117734_b0405","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/S0022-2836(03)00610-7","article-title":"Insights into protein-protein binding by binding free energy calculation and free energy decomposition for the Ras-Raf and Ras-RalGDS complexes","volume":"330","author":"Gohlke","year":"2003","journal-title":"J Mol Biol"}],"container-title":["Bioorganic & Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089624001482?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089624001482?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T20:50:32Z","timestamp":1778791832000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089624001482"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":81,"alternative-id":["S0968089624001482"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2024.117734","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of harmiprims, harmine-primaquine hybrids, as potent and selective anticancer and antimalarial compounds","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2024.117734","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"117734"}}